期刊
TRENDS IN NEUROSCIENCES
卷 43, 期 12, 页码 935-938出版社
CELL PRESS
DOI: 10.1016/j.tins.2020.10.010
关键词
-
资金
- CAPES [88887.507218/2020-00, 88887.507161/2020-00, 88887.185806/2018-00]
- CNPQ/INCT [465671/2014-4]
- CNPQ/ZIKA [440763/2016-9]
- CNPQ/FAPERGS/PRONEX [16/2551-0000475-7]
- FAPERGS [19/2551-0000700-0]
- CNPq [435642/2018-9, 312410/2018-2]
- Instituto Serrapilheira [Serra-1912-31365]
- EPSRC [EP/S032789/1]
- Wellcome Trust Multi-User Equipment grant [212885/Z/18Z]
- National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust
- King's College London
- EPSRC [EP/S032789/1] Funding Source: UKRI
A substantial fraction of coronavirus disease 2019 (COVID-19) patients experience neurological manifestations. Nevertheless, brain changes caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remain largely unknown. Here, we provide a brief overview of positron emission tomography (PET) applications that could advance current understanding of CNS pathophysiological alterations associated with SARS-CoV-2 infection.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据
分享论文
